HEADER PROTEIN BINDING, SIGNALING PROTEIN 21-JUN-10 3NKX TITLE IMPAIRED BINDING OF 14-3-3 TO RAF1 IS LINKED TO NOONAN AND LEOPARD TITLE 2 SYNDROME COMPND MOL_ID: 1; COMPND 2 MOLECULE: 14-3-3 PROTEIN ZETA/DELTA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PROTEIN KINASE C INHIBITOR PROTEIN 1, KCIP-1; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: PEPTIDE OF RAF PROTO-ONCOGENE SERINE/THREONINE-PROTEIN COMPND 8 KINASE; COMPND 9 CHAIN: P, Q; COMPND 10 FRAGMENT: PHOSPHORYLATED C-RAF PEPTIDE, UNP RESIDUES 255-264; COMPND 11 SYNONYM: PROTO-ONCOGENE C-RAF, CRAF, RAF-1; COMPND 12 EC: 2.7.11.1; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: YWHAZ; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN HUMANS. KEYWDS PROTEIN BINDING, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR B.SCHUMACHER,M.WEYAND,C.OTTMANN REVDAT 4 01-NOV-23 3NKX 1 REMARK LINK REVDAT 3 08-NOV-17 3NKX 1 REMARK REVDAT 2 26-FEB-14 3NKX 1 JRNL VERSN REVDAT 1 15-SEP-10 3NKX 0 JRNL AUTH M.MOLZAN,B.SCHUMACHER,C.OTTMANN,A.BALJULS,L.POLZIEN, JRNL AUTH 2 M.WEYAND,P.THIEL,R.ROSE,M.ROSE,P.KUHENNE,M.KAISER,U.R.RAPP, JRNL AUTH 3 J.KUHLMANN,C.OTTMANN JRNL TITL IMPAIRED BINDING OF 14-3-3 TO C-RAF IN NOONAN SYNDROME JRNL TITL 2 SUGGESTS NEW APPROACHES IN DISEASES WITH INCREASED RAS JRNL TITL 3 SIGNALING JRNL REF MOL.CELL.BIOL. V. 30 4698 2010 JRNL REFN ISSN 0270-7306 JRNL PMID 20679480 JRNL DOI 10.1128/MCB.01636-09 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 60.76 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 25804 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1359 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.46 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1889 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2660 REMARK 3 BIN FREE R VALUE SET COUNT : 100 REMARK 3 BIN FREE R VALUE : 0.3750 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3730 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 5 REMARK 3 SOLVENT ATOMS : 183 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.02 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.20000 REMARK 3 B22 (A**2) : 2.10000 REMARK 3 B33 (A**2) : -1.90000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.236 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.161 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.827 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.924 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3797 ; 0.022 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5126 ; 1.990 ; 1.972 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 473 ; 6.697 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 183 ;38.035 ;25.246 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 699 ;21.029 ;15.043 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 23 ;17.139 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 579 ; 0.161 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2829 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2368 ; 1.148 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3788 ; 2.227 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1429 ; 3.553 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1336 ; 5.881 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3NKX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 24-JUN-10. REMARK 100 THE DEPOSITION ID IS D_1000059958. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-AUG-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97809 REMARK 200 MONOCHROMATOR : LN2 COOLED FIXED-EXIT SI(111) REMARK 200 MONOCHROMATOR, SAGITTAL- REMARK 200 HORIZONTAL; DYNAMICALLY BENDABLE REMARK 200 MIRROR, MERIDIONAL-VERTICAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27180 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 60.760 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.05200 REMARK 200 R SYM (I) : 0.04950 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.50 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : 0.41600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.020 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1QJB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.93 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.92 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M (SODIUM PROPIONATE, SODIUM REMARK 280 CACODYLATE, BIS-TRIS PROPANE), 27% PEG 1500, 2MM DTT, PH 8.0, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.20500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 55.83500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.92500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 55.83500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.20500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.92500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4470 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22530 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -24.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, P, Q REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASP A 231 REMARK 465 THR A 232 REMARK 465 GLN A 233 REMARK 465 GLY A 234 REMARK 465 ASP A 235 REMARK 465 GLU A 236 REMARK 465 ALA A 237 REMARK 465 GLU A 238 REMARK 465 ALA A 239 REMARK 465 GLY A 240 REMARK 465 GLU A 241 REMARK 465 GLY A 242 REMARK 465 GLY A 243 REMARK 465 GLU A 244 REMARK 465 ASN A 245 REMARK 465 GLY B 71 REMARK 465 ALA B 72 REMARK 465 ASP B 231 REMARK 465 THR B 232 REMARK 465 GLN B 233 REMARK 465 GLY B 234 REMARK 465 ASP B 235 REMARK 465 GLU B 236 REMARK 465 ALA B 237 REMARK 465 GLU B 238 REMARK 465 ALA B 239 REMARK 465 GLY B 240 REMARK 465 GLU B 241 REMARK 465 GLY B 242 REMARK 465 GLY B 243 REMARK 465 GLU B 244 REMARK 465 ASN B 245 REMARK 465 GLN P 255 REMARK 465 GLN Q 255 REMARK 465 HIS Q 264 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 2 CG OD1 OD2 REMARK 470 LYS A 3 CG CD CE NZ REMARK 470 GLU A 5 CG CD OE1 OE2 REMARK 470 GLN A 8 CG CD OE1 NE2 REMARK 470 LYS A 9 CG CD CE NZ REMARK 470 LYS A 68 CE NZ REMARK 470 GLN A 77 CD OE1 NE2 REMARK 470 LYS A 157 CE NZ REMARK 470 LYS B 3 CG CD CE NZ REMARK 470 LYS B 68 CG CD CE NZ REMARK 470 GLU B 73 CG CD OE1 OE2 REMARK 470 LYS B 74 CG CD CE NZ REMARK 470 LYS B 75 NZ REMARK 470 GLN B 77 CD OE1 NE2 REMARK 470 ARG B 80 CD NE CZ NH1 NH2 REMARK 470 ASP B 136 CG OD1 OD2 REMARK 470 LYS B 139 CG CD CE NZ REMARK 470 LYS B 157 CD CE NZ REMARK 470 LYS B 158 CG CD CE NZ REMARK 470 GLU B 208 CG CD OE1 OE2 REMARK 470 LYS B 212 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG SER A 114 O HOH A 276 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OH TYR A 211 O ILE B 200 4545 1.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 41 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 PRO A 165 C - N - CA ANGL. DEV. = 9.6 DEGREES REMARK 500 LEU A 206 CA - CB - CG ANGL. DEV. = 15.9 DEGREES REMARK 500 VAL B 52 CB - CA - C ANGL. DEV. = -11.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 3 -23.06 -34.28 REMARK 500 GLN A 32 2.97 -57.73 REMARK 500 SER A 37 -179.02 -60.23 REMARK 500 ALA A 72 54.36 30.36 REMARK 500 ASN A 183 44.27 35.11 REMARK 500 LYS B 68 31.99 156.85 REMARK 500 ILE B 181 -61.85 -97.70 REMARK 500 SER B 184 77.15 -106.45 REMARK 500 GLU B 202 30.71 -145.55 REMARK 500 ASP B 204 -84.23 -46.17 REMARK 500 THR B 205 12.34 -33.72 REMARK 500 THR B 229 50.95 -94.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PPI A 247 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3M50 RELATED DB: PDB REMARK 900 STRUCTURE OF THE 14-3-3/PMA2 COMPLEX STABILIZED BY EPIBESTATIN REMARK 900 RELATED ID: 3M51 RELATED DB: PDB REMARK 900 STRUCTURE OF THE 14-3-3/PMA2 COMPLEX STABILIZED BY PYRROLIDONE1 REMARK 900 RELATED ID: 3LW1 RELATED DB: PDB REMARK 900 BINARY COMPLEX OF 14-3-3 SIGMA AND P53 PT387-PEPTIDE REMARK 900 RELATED ID: 3E6Y RELATED DB: PDB REMARK 900 STRUCTURE OF 14-3-3 IN COMPLEX WITH THE DIFFERENTIATION-INDUCING REMARK 900 AGENT COTYLENIN A REMARK 900 RELATED ID: 2O02 RELATED DB: PDB REMARK 900 PHOSPHORYLATION INDEPENDENT INTERACTIONS BETWEEN 14-3-3 AND REMARK 900 EXOENZYME S: FROM STRUCTURE TO PATHOGENESIS REMARK 900 RELATED ID: 2O98 RELATED DB: PDB REMARK 900 STRUCTURE OF THE 14-3-3 / H+-ATPASE PLANT COMPLEX DBREF 3NKX A 1 245 UNP P63104 1433Z_HUMAN 1 245 DBREF 3NKX B 1 245 UNP P63104 1433Z_HUMAN 1 245 DBREF 3NKX P 255 264 UNP P04049 RAF1_HUMAN 255 264 DBREF 3NKX Q 255 264 UNP P04049 RAF1_HUMAN 255 264 SEQRES 1 A 245 MET ASP LYS ASN GLU LEU VAL GLN LYS ALA LYS LEU ALA SEQRES 2 A 245 GLU GLN ALA GLU ARG TYR ASP ASP MET ALA ALA CYS MET SEQRES 3 A 245 LYS SER VAL THR GLU GLN GLY ALA GLU LEU SER ASN GLU SEQRES 4 A 245 GLU ARG ASN LEU LEU SER VAL ALA TYR LYS ASN VAL VAL SEQRES 5 A 245 GLY ALA ARG ARG SER SER TRP ARG VAL VAL SER SER ILE SEQRES 6 A 245 GLU GLN LYS THR GLU GLY ALA GLU LYS LYS GLN GLN MET SEQRES 7 A 245 ALA ARG GLU TYR ARG GLU LYS ILE GLU THR GLU LEU ARG SEQRES 8 A 245 ASP ILE CYS ASN ASP VAL LEU SER LEU LEU GLU LYS PHE SEQRES 9 A 245 LEU ILE PRO ASN ALA SER GLN ALA GLU SER LYS VAL PHE SEQRES 10 A 245 TYR LEU LYS MET LYS GLY ASP TYR TYR ARG TYR LEU ALA SEQRES 11 A 245 GLU VAL ALA ALA GLY ASP ASP LYS LYS GLY ILE VAL ASP SEQRES 12 A 245 GLN SER GLN GLN ALA TYR GLN GLU ALA PHE GLU ILE SER SEQRES 13 A 245 LYS LYS GLU MET GLN PRO THR HIS PRO ILE ARG LEU GLY SEQRES 14 A 245 LEU ALA LEU ASN PHE SER VAL PHE TYR TYR GLU ILE LEU SEQRES 15 A 245 ASN SER PRO GLU LYS ALA CYS SER LEU ALA LYS THR ALA SEQRES 16 A 245 PHE ASP GLU ALA ILE ALA GLU LEU ASP THR LEU SER GLU SEQRES 17 A 245 GLU SER TYR LYS ASP SER THR LEU ILE MET GLN LEU LEU SEQRES 18 A 245 ARG ASP ASN LEU THR LEU TRP THR SER ASP THR GLN GLY SEQRES 19 A 245 ASP GLU ALA GLU ALA GLY GLU GLY GLY GLU ASN SEQRES 1 B 245 MET ASP LYS ASN GLU LEU VAL GLN LYS ALA LYS LEU ALA SEQRES 2 B 245 GLU GLN ALA GLU ARG TYR ASP ASP MET ALA ALA CYS MET SEQRES 3 B 245 LYS SER VAL THR GLU GLN GLY ALA GLU LEU SER ASN GLU SEQRES 4 B 245 GLU ARG ASN LEU LEU SER VAL ALA TYR LYS ASN VAL VAL SEQRES 5 B 245 GLY ALA ARG ARG SER SER TRP ARG VAL VAL SER SER ILE SEQRES 6 B 245 GLU GLN LYS THR GLU GLY ALA GLU LYS LYS GLN GLN MET SEQRES 7 B 245 ALA ARG GLU TYR ARG GLU LYS ILE GLU THR GLU LEU ARG SEQRES 8 B 245 ASP ILE CYS ASN ASP VAL LEU SER LEU LEU GLU LYS PHE SEQRES 9 B 245 LEU ILE PRO ASN ALA SER GLN ALA GLU SER LYS VAL PHE SEQRES 10 B 245 TYR LEU LYS MET LYS GLY ASP TYR TYR ARG TYR LEU ALA SEQRES 11 B 245 GLU VAL ALA ALA GLY ASP ASP LYS LYS GLY ILE VAL ASP SEQRES 12 B 245 GLN SER GLN GLN ALA TYR GLN GLU ALA PHE GLU ILE SER SEQRES 13 B 245 LYS LYS GLU MET GLN PRO THR HIS PRO ILE ARG LEU GLY SEQRES 14 B 245 LEU ALA LEU ASN PHE SER VAL PHE TYR TYR GLU ILE LEU SEQRES 15 B 245 ASN SER PRO GLU LYS ALA CYS SER LEU ALA LYS THR ALA SEQRES 16 B 245 PHE ASP GLU ALA ILE ALA GLU LEU ASP THR LEU SER GLU SEQRES 17 B 245 GLU SER TYR LYS ASP SER THR LEU ILE MET GLN LEU LEU SEQRES 18 B 245 ARG ASP ASN LEU THR LEU TRP THR SER ASP THR GLN GLY SEQRES 19 B 245 ASP GLU ALA GLU ALA GLY GLU GLY GLY GLU ASN SEQRES 1 P 10 GLN ARG SER THR SEP THR PRO ASN VAL HIS SEQRES 1 Q 10 GLN ARG SER THR SEP THR PRO ASN VAL HIS MODRES 3NKX SEP P 259 SER PHOSPHOSERINE MODRES 3NKX SEP Q 259 SER PHOSPHOSERINE HET SEP P 259 10 HET SEP Q 259 10 HET PPI A 247 5 HETNAM SEP PHOSPHOSERINE HETNAM PPI PROPANOIC ACID HETSYN SEP PHOSPHONOSERINE FORMUL 3 SEP 2(C3 H8 N O6 P) FORMUL 5 PPI C3 H6 O2 FORMUL 6 HOH *183(H2 O) HELIX 1 1 ASP A 2 ALA A 16 1 15 HELIX 2 2 ARG A 18 GLN A 32 1 15 HELIX 3 3 SER A 37 THR A 69 1 33 HELIX 4 4 ALA A 72 PHE A 104 1 33 HELIX 5 5 GLN A 111 VAL A 132 1 22 HELIX 6 6 GLY A 135 MET A 160 1 26 HELIX 7 7 HIS A 164 ILE A 181 1 18 HELIX 8 8 SER A 184 ALA A 201 1 18 HELIX 9 9 GLU A 202 LEU A 206 5 5 HELIX 10 10 SER A 210 THR A 229 1 20 HELIX 11 11 ASP B 2 ALA B 16 1 15 HELIX 12 12 ARG B 18 GLU B 31 1 14 HELIX 13 13 SER B 37 GLN B 67 1 31 HELIX 14 14 GLU B 73 PHE B 104 1 32 HELIX 15 15 PHE B 104 ALA B 109 1 6 HELIX 16 16 GLN B 111 GLU B 131 1 21 HELIX 17 17 ASP B 136 MET B 160 1 25 HELIX 18 18 HIS B 164 ILE B 181 1 18 HELIX 19 19 SER B 184 ALA B 201 1 18 HELIX 20 20 SER B 210 THR B 229 1 20 LINK C THR P 258 N SEP P 259 1555 1555 1.33 LINK C SEP P 259 N THR P 260 1555 1555 1.31 LINK C THR Q 258 N SEP Q 259 1555 1555 1.33 LINK C SEP Q 259 N THR Q 260 1555 1555 1.33 CISPEP 1 GLY A 71 ALA A 72 0 -5.52 CISPEP 2 VAL P 263 HIS P 264 0 -20.69 SITE 1 AC1 4 GLN A 219 ARG A 222 GLN B 219 ARG B 222 CRYST1 72.410 83.850 111.670 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013810 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011926 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008955 0.00000